Is it safe for patients on methotrexate to receive the inactivated influenza vaccine, and should methotrexate be paused before or after vaccination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Methotrexate and Flu Vaccine

Patients on methotrexate should receive the inactivated influenza vaccine, and methotrexate should be held for 2 weeks AFTER vaccination if disease activity allows. 1

Safety of Vaccination

The inactivated influenza vaccine is safe for patients on methotrexate. The FDA label notes that "immunization may be ineffective when given during methotrexate therapy" but does not contraindicate inactivated vaccines 2. Live vaccines are contraindicated, but the standard flu vaccine is inactivated and poses no safety concerns.

Medication Management Strategy

When to Hold Methotrexate

Hold methotrexate for 2 weeks AFTER receiving the influenza vaccine - not before 1. This timing is critical because:

  • Methotrexate significantly blunts vaccine immunogenicity when continued through vaccination 1
  • Two RCTs demonstrated improved vaccine responses when methotrexate was held after vaccination 3, 4
  • Holding for 2 weeks post-vaccination resulted in 75.5% satisfactory vaccine response versus 54.5% when methotrexate was continued 3
  • Seroprotection rates were 10-16% higher across all four influenza strains when methotrexate was held 3

Duration of Hold

Recent evidence suggests 1 week may be sufficient rather than 2 weeks:

  • A 2023 RCT found that holding methotrexate for 1 week after vaccination was non-inferior to 2 weeks (68.9% vs 75.0% satisfactory response, p=0.364) 5
  • This shorter duration may improve adherence and reduce flare risk

Critical Caveats

Only hold methotrexate if disease activity allows 1. The decision requires:

  • Assessment of current disease activity and flare risk
  • Shared decision-making with the patient
  • Understanding that RA flare rates were 34-39% when methotrexate was held for 2-4 weeks 4

Practical Algorithm

  1. Assess disease stability: If active flare or unstable disease → vaccinate but continue methotrexate
  2. If disease is stable: Vaccinate and hold methotrexate for 1-2 weeks after vaccination
  3. If uncertain about holding: Give the vaccine anyway and consult with rheumatology afterward 1

Important Clinical Pitfall

Never delay or skip vaccination because you're unsure about holding methotrexate. The 2022 ACR guideline explicitly states that non-rheumatology providers should give the influenza vaccine even if uncertain about medication management, then consult with the patient's rheumatologist 1. Missing the vaccination opportunity is worse than suboptimal vaccine response.

Other Immunosuppressive Medications

For context, continue all other immunosuppressive medications (except rituximab) during influenza vaccination 1. The methotrexate hold is unique to influenza vaccine - for all other non-live vaccines, continue methotrexate 1.

Mechanism

Methotrexate has rapid intracellular turnover with MTX-polyglutamate levels peaking at 24 hours and clearing within 48 hours after withdrawal 6. This explains why brief interruption can restore vaccine responses without requiring prolonged discontinuation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.